These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 874319)

  • 1. Inhibition of complement by mouse serum: selective inactivation of the fourth component of human complement.
    Mandle RJ; McConnell-Mapes JA; Nilsson UR
    J Immunol; 1977 Jul; 119(1):180-6. PubMed ID: 874319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
    von Zabern I; Bloom EL; Chu V; Gigli I
    J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a C4b binding site on the C2b domain of C2.
    Oglesby TJ; Accavitti MA; Volanakis JE
    J Immunol; 1988 Aug; 141(3):926-31. PubMed ID: 3397535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity (author's transl)].
    Berthoux FX; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Feb; 25(2):105-8. PubMed ID: 322041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse C3b/C4b inactivator: purification and properties.
    Kai S; Fujita T; Gigli I; Nussenzweig V
    J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly defined murine alloantigen controlled by the S region of the H-2 complex: molecular association with the fourth component of complement.
    Spinella DG; Passmore HC
    J Immunol; 1983 Feb; 130(2):824-8. PubMed ID: 6184407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I; Sorvillo J; Halbwachs-Mecarelli L
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
    Kinoshita T; Medof ME; Nussenzweig V
    J Immunol; 1986 May; 136(9):3390-5. PubMed ID: 2420889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum.
    Cooper NR
    J Exp Med; 1975 Apr; 141(4):890-903. PubMed ID: 47888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.
    Ji YH; Fujita T; Hatsuse H; Takahashi A; Matsushita M; Kawakami M
    J Immunol; 1993 Jan; 150(2):571-8. PubMed ID: 8419490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogeny of C4b-C3b cleaving activity: similar fragmentation patterns of human C4b and C3b produced by lower animals.
    Kaidoh T; Gigli I
    J Immunol; 1987 Jul; 139(1):194-201. PubMed ID: 3295051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
    Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
    Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
    Fujita T; Tamura N
    J Exp Med; 1983 Apr; 157(4):1239-51. PubMed ID: 6601177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.